These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32546255)

  • 21. Anti-tuberculous drug induced liver injury - Do we need to rethink?
    Pandey J; Madaan P; Saini L; Verma S
    Indian J Tuberc; 2020 Apr; 67(2):260-261. PubMed ID: 32553322
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver function testing in African patients on treatment for tuberculosis.
    Davies PD
    East Afr Med J; 1985 Jul; 62(7):486-90. PubMed ID: 4076028
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis associated with prothionamide for treatment of multidrug-resistant tuberculosis.
    Hsu HL; Bai KJ; Chiang YC; Lin SJ; Yu MC
    J Formos Med Assoc; 2010 Dec; 109(12):923-7. PubMed ID: 21195892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short course chemotherapy for childhood tuberculosis.
    Biddulph J
    Pediatr Infect Dis J; 1990 Nov; 9(11):794-801. PubMed ID: 2263427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are antitubercular drugs prescribed correctly and scientifically?
    Sahoo RC
    J Assoc Physicians India; 1994 Apr; 42(4):349-50. PubMed ID: 7860579
    [No Abstract]   [Full Text] [Related]  

  • 27. [Intravenous morphazinamide. Tolerance of the drug and therapeutic effects].
    Celotti A
    Minerva Med; 1965 Sep; 56(71):2892-7. PubMed ID: 5322270
    [No Abstract]   [Full Text] [Related]  

  • 28. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus.
    Ungo JR; Jones D; Ashkin D; Hollender ES; Bernstein D; Albanese AP; Pitchenik AE
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1871-6. PubMed ID: 9620920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 30. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Liver damage caused by the continued use of chemotherapy of pulmonary tuberculosis].
    Yamazaki M; Endo K; Noguchi T; Nakano M
    Iryo; 1966 Apr; 20(4):347-53. PubMed ID: 5974193
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparison of drug-induced hepatitis occurring in elderly and younger patients during anti-tuberculosis treatment with a regimen including pyrazinamide].
    Miyazawa N; Horita N; Tomaru K; Tsukahara T; Takahashi R; Sasaki M; Ishigatsubo Y
    Kekkaku; 2013 Mar; 88(3):297-300. PubMed ID: 23672170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
    Saigal S; Agarwal SR; Nandeesh HP; Sarin SK
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1028-32. PubMed ID: 11595068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma.
    Dietrich CG; Gartung C; Lorenzen J; Geier A; Wasmuth HE; Matern S; Lammert F
    Ann Hepatol; 2004; 3(3):118-20. PubMed ID: 15505599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: A systematic review and meta-analysis.
    Chang TE; Huang YS; Chang CH; Perng CL; Huang YH; Hou MC
    J Chin Med Assoc; 2018 Feb; 81(2):111-118. PubMed ID: 29198550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter?
    Chang KC; Leung CC; Yew WW; Tam CM
    Eur Respir J; 2007 Feb; 29(2):347-51. PubMed ID: 17005575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis due to anti-tuberculous drugs.
    Aggarwal NP
    Indian J Chest Dis Allied Sci; 1992; 34(4):231-2. PubMed ID: 1302758
    [No Abstract]   [Full Text] [Related]  

  • 39. LIVER FUNCTION DISORDERS IN PATIENTS WITH FIRST DIAGNOSED PULMONARY TUBERCULOSIS.
    Hryshchuk L; Okusok O; Boiko T; Lykhatska H; Radetska L
    Georgian Med News; 2017 Oct; (271):49-55. PubMed ID: 29099701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isoniazid-induced hepatic failure. Report of a case].
    Pereira RM; Tresoldi AT; Hessel G
    Arq Gastroenterol; 2000; 37(1):72-5. PubMed ID: 10962632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.